A nurse in a provider’s office is monitoring serum electrolytes for four older adult clients who take digoxin (Lanoxin) and furosemide (Lasix). Which of the following electrolyte values puts a client at risk for digoxin toxicity?
Calcium 9.2 mg/dL
Calcium 10.3 mg/dL
Potassium 3.4 mEq/L
Potassium 4.8 mEq/L
The Correct Answer is C
Digoxin is a cardiac glycoside that inhibits the sodium-potassium ATPase pump to improve myocardial contractility and facilitate vagal tone. Toxicity risk increases when hypokalemia occurs, typically below 3.5 mEq/L, often due to concurrent loop diuretic therapy.
Rationale for correct answer
C. A serum potassium level of 3.4 mEq/L indicates hypokalemia, as the standard reference range is 3.5 to 5.0 mEq/L. Low extracellular potassium increases digoxin binding to the ATPase pump, significantly elevating the risk of digitalis toxicity. The nurse must recognize that even mild potassium deficits can trigger life-threatening ventricular dysrhythmias in the elderly. This value requires immediate clinical intervention and potential potassium supplementation to ensure patient safety.
Rationale for incorrect answers
A. A serum calcium level of 9.2 mg/dL is within the normal range of 9.0 to 10.5 mg/dL for an adult. While hypercalcemia can increase the risk of digoxin-induced arrhythmias, this specific value does not represent a metabolic risk. The client is not at an increased risk of toxicity based on this stable laboratory finding. Monitoring should continue, but no immediate corrective action is required for this parameter.
B. The calcium value of 10.3 mg/dL remains within the standard limits of the physiological reference range for serum calcium levels. Although it is near the upper threshold, it is not considered pathological hypercalcemia, which would be necessary to potentiate digitalis toxicity. The client’s cardiac sensitivity to digoxin is not adversely affected by this specific electrolyte concentration. Continuous surveillance is appropriate as part of routine geriatric care in a primary setting.
D. A potassium level of 4.8 mEq/L is a perfectly normal value, falling safely within the 3.5 to 5.0 mEq/L range. This level provides sufficient competition for the binding sites on the sodium-potassium pump, effectively maintaining a safe therapeutic drug profile. There is no evidence of hypokalemia that would predispose this client to the toxic manifestations of Lanoxin. The nurse should document this as a stable and therapeutic laboratory result.
Test-taking strategy
- Identify the core drug interaction: Recognize that the combination of digoxin and furosemide is high-risk because loop diuretics waste potassium.
- Establish reference ranges:
- Potassium: 3.5 to 5.0 mEq/L.
- Calcium: 9.0 to 10.5 mg/dL.
- Define digoxin toxicity risk: Recall that hypokalemia (low potassium), hypomagnesemia (low magnesium), and hypercalcemia (high calcium) are the primary triggers.
- Evaluate the choices:
- Choices 1, 2, and 4 are all within normal physiological limits.
- Choice 3 (3.4 mEq/L) is the only abnormal value and is specifically below the potassium threshold.
- Apply prioritization of risk: Select the value that represents a physiological deficit known to increase drug-receptor binding.
- Consider the patient population: Older adults have reduced renal clearance, making them even more susceptible to electrolyte-driven drug toxicity.
Take home points
- Hypokalemia is the most significant electrolyte imbalance increasing digoxin toxicity risk because it reduces competition for binding sites on the sodium-potassium ATPase pump.
- Loop diuretics like furosemide frequently cause potassium depletion, necessitating frequent serum electrolyte monitoring and often potassium-rich diets or supplements.
- Clinical signs of digoxin toxicity include gastrointestinal distress, bradycardia, and visual disturbances such as yellow-green halos or blurred vision.
- Therapeutic serum digoxin levels range from 0.5 to 2.0 ng/mL, but toxicity can occur at lower levels if significant electrolyte disturbances are present.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
The fixed-dose combination of hydralazine and isosorbide dinitrate acts through complementary vasodilation mechanisms to optimize cardiac hemodynamics. Hydralazine primarily facilitates arteriolar dilation, reducing systemic vascular resistance and afterload, while isosorbide dinitrate promotes venous dilation, decreasing preload. This synergistic approach effectively manages heart failure by mitigating the high ventricular wall stress. It is particularly indicated for patients with reduced ejection fraction who remain symptomatic despite standard therapy or as a first-line option in specific ethnic populations.
Rationale for correct answer
D. Hydralazine reduces the resistance against which the left ventricle must pump, while isosorbide dinitrate decreases the volume returning to the heart. This combined reduction in afterload and preload significantly lowers the metabolic oxygen demand of the myocardium. By decreasing the cardiac workload, the heart can pump more efficiently without overexertion. This accurately explains the hemodynamic benefits of dual vasodilator therapy to the client.
Rationale for incorrect answers
A. Neither hydralazine nor isosorbide dinitrate possesses biochemical properties that interfere with the HMG-CoA reductase pathway or cholesterol absorption. Managing cholesterol levels requires statins or other lipid-lowering agents, not systemic vasodilators. This explanation is scientifically inaccurate as it confuses cardiovascular hemodynamic support with lipid metabolism.
B. Vasodilators facilitate cardiac emptying but do not directly promote the renal excretion of sodium and water like diuretic therapy. While they may decrease the severity of congestion, they cannot replace the natriuretic effect of drugs like furosemide. Patients with fluid overload typically require both classes to manage the total volume status effectively.
C. Hydralazine and isosorbide dinitrate do not interact with the renal tubules or the mineralocorticoid receptors to influence electrolyte secretion. They are not potassium-sparing agents and have no clinical impact on the potassium wasting often induced by loop diuretics. Protecting against potassium loss requires potassium supplements or specific diuretics like spironolactone.
Test-taking strategy
- Identify drug mechanisms: Recall that hydralazine is an arterial vasodilator (afterload) and nitrates are venous vasodilators (preload).
- Apply heart failure principles: The goal of treating heart failure is to make it easier for the weak heart to pump.
- Analyze hemodynamic effects:
- If arteries are dilated, the heart pumps against less pressure.
- If veins are dilated, the heart receives less volume.
- Both lead to a direct reduction in cardiac workload (Option 4).
- Rule out non-related categories:
- Lipids/cholesterol are managed by different classes (Rule out Option 1).
- Diuretics/electrolytes are renal-acting, whereas these are vascular-acting (Rule out Options 2 and 3).
- Prioritize the "Best" response: Select the answer that addresses the core physiological benefit for a heart failure patient.
Take home points
- The combination of hydralazine and isosorbide dinitrate is a powerful strategy to reduce both preload and afterload in heart failure.
- This drug combination is specifically proven to improve survival and reduce hospitalizations in patients with heart failure with reduced ejection fraction.
- Nurses must monitor for reflex tachycardia and severe headache, which are common side effects due to the potent vasodilatory effects.
- Unlike ACE inhibitors or ARBs, this combination does not significantly impact renal function or serum potassium levels.
Correct Answer is ["A","C","F"]
Explanation
Loop diuretics inhibit the Na+/K+/2Cl- symporter within the thick ascending limb of the loop of Henle, inducing potent natriuresis and subsequent fluid volume reduction. This class addresses congestive heart failure and pulmonary edema but risks significant hypokalemia, prerenal azotemia, and ototoxicity. Serum potassium must remain between 3.5 and 5.0 mEq/L. Contraindications include anuria or severe sulfonamide hypersensitivity.
Rationale for correct answers
A. Establishing a consistent administration schedule ensures stable pharmacokinetic levels and optimizes therapeutic outcomes for the patient. Taking the medication in the morning specifically prevents nocturia, which can disrupt sleep and increase fall risks. This routine promotes pharmacological adherence in chronic management.
C. Loop diuretics significantly reduce intravascular volume and lower systemic venous pressure, which can lead to orthostatic hypotension. Rising slowly allows time for baroreceptor compensation to prevent syncope and subsequent injuries. This instruction is vital for ensuring the safety of older adult patients.
F. Muscle weakness is a primary clinical manifestation of hypokalemia, while dizziness often indicates significant dehydration or hypotension. These symptoms signal dangerous electrolyte imbalances or hemodynamic instability that require immediate medical evaluation. Reporting these findings early prevents lethal cardiac arrhythmias.
Rationale for incorrect answers
B. Diuretics for chronic heart failure are intended for consistent daily use to maintain a stable euvolemic state. Taking the medication only when edema is visible allows for dangerous fluid accumulation in the pulmonary vasculature. Effective management requires proactive dosing rather than reactive, symptom-based administration.
D. Prescribing a high fluid intake of 8 glasses daily directly contradicts the therapeutic goal of treating heart failure. Excessive water consumption can exacerbate volume overload and worsen symptoms like dyspnea and orthopnea. Fluid intake must be carefully balanced or restricted based on the patient's renal and cardiac status.
E. Loop diuretics are non-potassium-sparing agents that promote the renal excretion of potassium into the tubular lumen. Patients actually require increased intake of potassium-rich foods to offset the drug-induced losses and prevent hypokalemia. Advising the avoidance of potassium is incorrect and potentially life-threatening for this medication class.
Test-taking strategy
- Identify the physiological priority: The client is an older adult with heart failure. The primary goals are managing volume while preventing injury from drug-induced hypotension.
- Apply knowledge of diuretic classes: Distinguish between loop diuretics and potassium-sparing diuretics.
- Since loop diuretics waste potassium, any choice suggesting the avoidance of potassium (option 5) is scientifically incorrect.
- Prioritize patient safety and stability:
- Consistent timing (option 1) ensures the drug works throughout the day and protects sleep.
- Postural safety (option 3) addresses the high risk of orthostatic changes.
- Symptom reporting (option 6) focuses on the most dangerous metabolic and hemodynamic complications.
- Evaluate the disease process: Heart failure often requires fluid restriction, not high-volume hydration (option 4). Furthermore, chronic medications are rarely used on a "PRN" or as-needed basis for physical swelling (option 2) unless specified for minor symptoms, as consistent dosing is required to prevent pulmonary congestion.
Take home points
- Loop diuretics like furosemide or bumetanide require patients to rise slowly to prevent syncope associated with orthostatic hypotension.
- Daily morning administration is recommended to achieve peak diuresis during the day and prevent nocturnal sleep disruption.
- Clinical signs of hypokalemia, such as muscle weakness or cramping, must be reported immediately to prevent cardiac conductivity issues.
- Patients on loop diuretics should generally increase their consumption of potassium-rich foods to maintain serum levels ≥ 3.5 mEq/L.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.